基因组健康

GHDX NASDAQ
57.20
+0.92
+1.63%
已收盘, 17:15 07/15 EDT
开盘
56.59
昨收
56.28
最高
57.53
最低
55.50
成交量
30.28万
成交均量(3M)
50.41万
52周最高
92.18
52周最低
50.77
换手率
0.82%
市值
21.21亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供基因组健康 GHDX股票价格,基因组健康股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Genomic Health, Inc. is a healthcare company that provides genomic-based diagnostic tests to personalize cancer treatment. The Company develops and commercializes genomic-based clinical laboratory services. The Company's Oncotype IQ Genomic Intelligence Platform is consisted of its flagship line of Oncotype DX gene expression tests, as well as its Oncotype SEQ Liquid Select test. Its research and development activities are focused on developing a pipeline of tests to optimize the treatment of various cancers including breast, colon, prostate and other cancers. It offers its Oncotype DX tests as a clinical laboratory service, where it analyzes the expression levels of genes in tumor tissue samples and provides physicians with a quantitative gene expression profile expressed as a single quantitative score, which it calls a Recurrence Score for invasive breast cancer and colon cancer, a DCIS Score for ductal carcinoma in situ (DCIS), and a Genomic Prostate Score, for prostate cancer.
展开 >

最近浏览

名称
价格
涨跌幅